引用本文
  •    [点击复制]
  •    [点击复制]
PDF HTML全文阅读
本文已被:浏览 443次   下载 342 本文二维码信息
码上扫一扫!
多种油脂肪乳与中/长链脂肪乳剂的耐受性与安全性比较
康庆伟,李秀玲,贾媛,崔云峰,柴国胜
天津市中西医结合医院天津 300100
摘要:
目的:探讨多种油脂肪乳与中/长链脂肪乳剂对肠外营养(PN)治疗患者的耐受性与安全性。方法:选取2023年1月—2024年6月我院收治的98例行PN治疗的患者,随机分为两组各49例,试验组脂质乳剂为多种油脂肪乳,对照组脂质乳剂为中/长链脂肪乳剂。比较两组PN治疗前后的营养指标、炎症指标、肝肾功能及主观整体评估(SGA)评分。结果:治疗后,两组血红蛋白(Hb)、白蛋白(ALB)均较治疗前提高,且试验组ALB高于对照组,差异有统计学意义(P <0.05);对照组的C反应蛋白(CRP)无明显改变,而试验组CRP较治疗前降低,且低于对照组,差异有统计学意义(P <0.05)。两组治疗前后谷丙转氨酶(ALT)、谷草转氨酶(AST)、肌酐(Cr)差异均无统计学意义(P >0.05)。治疗后,两组SGA评分均提高,试验组高于对照组,差异有统计学意义(P <0.05)。两组均未出现机械、代谢性、感染性并发症。结论:多种油脂肪乳在改善机体营养状况及微炎症状态方面具有优势,且不会增加肝肾负担,耐受性好,安全性高,适用于PN治疗患者。
关键词:  肠外营养治疗  多种油脂肪乳  中/长链脂肪乳  耐受性  安全性
DOI:10.3969/j.issn.1007-6948.2025.04.018
投稿时间:2025-02-06
基金项目:
Comparison of tolerance and safety of multi-oil fat emulsions and medium / long chain fat emulsions
KANG Qing-wei,LI Xiu-ling,JIA yuan
Tianjin Hospital of ITCWM Nankai Hospital, Tianjin300100, China
Abstract:
Objective To investigate the tolerability and safety of multi-oil fat emulsion and medium/long chain fat emulsion in patients treated with parenteral nutrition (PN). Methods A total of 98 patients receiving long-term PN treatment from January 2023 to June 2024 were randomly divided into two groups, 49 cases in each group. The experimental group was treated with multi-oil fat emulsion, while the control group was treated with medium/long chain fat emulsion. Nutritional indexes, inflammatory indexes, liver and kidney function and subjective global assessment (SGA) scores were collected before and after PN treatment. Results Hemoglobin (Hb) and albumin (ALB) were both higher than before treatment, and ALB in the experimental group was higher than that in the control group, with statistical significance (P <0.05). There was no significant change in C-reactive protein (CRP) in the control group, while CRP in the experimental group was lower than that before treatment, and the comparison was statistically significant (P <0.05). There were no significant changes in alanine aminotransferase (ALT), aspartate aminotransferase (AST) and creatinine (Cr) in two groups before and after treatment (P >0.05). After treatment, the SGA score of both groups was increased, and the experimental group was higher than the control group, with statistical significance (P <0.05). There were no mechanical, metabolic or infectious complications in both groups. Conclusion Multi-oil fat emulsion has advantages in improving the nutritional status and micro-inflammatory state of the body, and does not increase the burden of liver and kidney, good tolerance, high safety, suitable for PN treatment patients.
Key words:  Parenteral nutrition therapy  multi-oil fat emulsion injection  medium/long chain fat emulsion  tolerability

用微信扫一扫

用微信扫一扫